Biotechnology News

July 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the second quarter ended June 30, 2012. The Company will host a conference call and webcast today at 5:00 p.m. ET (details below)....

July 19, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (1:30 p.m. BST) on Thursday, July 26, 2012, to discuss the company’s financial results for the first quarter of fiscal 2013. Management will review...

July 19, 2012

BEDFORD, Mass--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2012 financial results after the close of the market on Wednesday, August 1, 2012. The company plans to hold a...

July 19, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's "2012 CRO Quality Benchmarking - Phase I Service Providers" profiles the clinical pharmacology services of 12 Phase I CROs. The report also ranks attributes that drive vendor selection.

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems presents data on hemostasis monitoring at AACC 2012. T2Hemostasis offers rapid and direct monitoring plus measurement of anti-platelet drug effectiveness.

July 19, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces it has signed a binding...

July 19, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (Nasdaq: DARA) announced today the appointment of Stephen O. Jaeger to the DARA board of directors. Mr. Jaeger has served on the boards of a variety of private and public companies across the...

July 19, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx® Receives North American Product Leadership Award in the Molecular Diagnostics Market from Frost & Sullivan. Test for Cervical Cancer Described as the “Gold Standard for Gynecological Care."

July 19, 2012

LONDON--(BUSINESS WIRE)--New "Research Report on Chinese Chemosynthetic Polypeptide Drug Industry, 2012" worked out by China Research and Intelligence has been recently published by Market Publishers Ltd.

July 19, 2012

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Pfizer announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/...

July 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of fibromyalgia, Eli Lilly/Boehringer Ingelheim’s Cymbalta was...

July 19, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--New SEEDS supplier added to Premier’s high risk OBGYN specialty products portfolio

July 19, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus to release Q2 2012 results on August 2.

July 19, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--First Patient Enrolled for Dual-Site Physician-IND Study at University of Texas Health Sciences Center at San Antonio and Scott and White Texas A&M

July 19, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. announced today that an $8.5 million milestone was achieved in its collaboration with Amgen. The milestone was achieved after Amgen reached a pre-defined patient enrollment level

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended June 30, 2012 before the U.S. financial markets open on Thursday, July 26,...

July 19, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics today announced the pricing of its initial public offering of 7,500,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts. The shares are...

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its second-quarter 2012 financial results before the market opens on Thursday, August 2, 2012. Management will conduct a conference...

July 19, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. will host webcasts and conference calls to discuss its second-quarter 2012 financial results and of its annual meeting of stockholders on July 25 and 26, 2012, respectively.

July 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced financial results for the second quarter and confirmed its full-year 2012 financial outlook. Baxter reported net income of $661 million in the second quarter,...

July 19, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the official opening of the Company’s new corporate headquarters at the Ardsley Park life science campus in Ardsley, New York. The new facility, which is...

July 19, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

July 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. today announced that it has entered into a manufacturing services agreement with Stichting Sanquin Bloedvoorziening (Sanquin Blood Supply Foundation) in the Netherlands.

July 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst to report second quarter 2012 financial results on August 2, 2012 at 11 a.m. ET.

July 19, 2012

SAO PAULO, BRAZIL--(BUSINESS WIRE)--Covidien's Solitaire FR Revascularization Device, used to restore blood flow to the brain in patients suffering acute ischemic stroke, has been approved by Brazil’s National Health Surveillance Agency

July 19, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: · BI-204 (acute coronary syndrome) did not reach the primary endpoint in the phase IIa GLACIER study. A decision on the future of the program will be taken later this year. · After concluding...

July 19, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine...

July 19, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Paris:DBV) (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today the appointment of Mr. Stef Koppelman, PhD as...

July 19, 2012

SEATTLE & TOKYO--(BUSINESS WIRE)--Acucela Inc., a clinical stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 3 clinical...

July 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will announce its second quarter 2012 financial results on Monday, July 30, 2012 after the financial markets close. The company will host a conference call at 5...

July 18, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.225 per ordinary share. The dividend is payable on August 16, 2012, to shareholders of record on July 30,...

July 18, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, August 2, 2012, after market close, the Company will...

July 18, 2012

SIOUX FALLS, S.D.--(BUSINESS WIRE)--The South Dakota Biotechnology Association is helping organize the first annual Northern Plains Science Festival as a way to encourage families to explore science, technology, engineering and mathematics. “...

July 18, 2012

SAN FRANCISCO--(BUSINESS WIRE)--SINET announces high-profile keynotes for August 8th Innovation Summit on cybersecurity in Chicago: Dr. Tara O'Toole, DHS, and Vice Admiral Michael Rogers, Commander of the U.S. Fleet Cyber Command.

July 18, 2012

SOMERSET, N.J. & JERSEY CITY, N.J.--(BUSINESS WIRE)--Alliance Life Sciences Consulting Group and Adjility Consulting Announce Merger, Create Global Enterprise with Expanded Capabilities

July 18, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces France Grants ILUVIEN marketing authorization for treatment of chronic diabetic macular edema

July 18, 2012

CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a medical device company, announced it has raised a $3.5 million round of funding, led by Boston Scientific and Glengary LLC. Also joining in the round were current investors Case Tech Ventures,...

July 18, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Calling top lifescience and healthcare innovators seeking funding to apply for LifeScienceFest

July 18, 2012

WASHINGTON--(BUSINESS WIRE)--Doug Peddicord, PhD, Executive Director of the ACRO, made the following statement regarding the European Commission’s proposal for the regulation of clinical trials.

July 18, 2012

PLANEGG, Germany--(BUSINESS WIRE)--Participating in the European AirPROM project to unravel the complexity of airway diseases and improve personalized healthcare, Biomax has built the knowledge management infrastructure to facilitate the...

July 18, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida's partner Alimera announces capital raise to fund development and commercialization of ILUVIEN drug for diabetic macular edema.

July 18, 2012

MADISON, Wis.--(BUSINESS WIRE)--BioForward announced that applications were being accepted for its Emerging Company Showcase. Wisconsin-based companies who are developing or have bioscience product or services encouraged to apply!

July 18, 2012

UNIONDALE, N.Y.--(BUSINESS WIRE)--Angion Biomedica Corp. announced today that the first patient was dosed in a Phase II multicenter clinical trial evaluating BB3 for the treatment of heart attack (acute myocardial infarction). The first patient,...

July 18, 2012

SAN FRANCISCO & PARIS--(BUSINESS WIRE)--SpineGuard’s PediGuard® device reduces by 30% spine surgeons’ radiation exposure from fluoroscopy while maintaining a 97.5% accurate pedicle screw placement

July 18, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Crux Biomedical announced it has received U.S. Food and Drug Administration (FDA) clearance for its novel inferior vena cava filter (VCF) with bi-directional retrieval.